However, among the limited number of genes showing both gene expression and methylation variation, Cysteine Sulfinic Acid Decarboxylase CSAD and FGF21 were previously noted in two independent studies to be able to mitigate lipid accumulation and steatosis in HFD-treated mice [60,61]. The gene discussed is CSAD; the disease is steatosis.